Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice

Life Sciences

Volumn 118, Issue 1, 2014, Pages 7-14

  Lee, Ho Sung ^a   Nam, Yunsung ^a   Chung, YoonHee ^a   Kim, Hak Rim ^b   Park, Eon Sub ^a   Chung, Su Jin ^a   Kim, Jung Hyo ^a   Sohn, Uy Dong ^a   Kim, Hyoung Chun ^c   Oh, Keon Woong ^a,d   Jeong, Ji Hoon ^a  

^a Chung Ang University   (South Korea)

^b Dankook University   (South Korea)

^c Kangwon National University   (South Korea)

^d Christmas Clinic   (South Korea)

Author keywords

Apo E; Dyslipidemia; High fat diet; Non alcoholic fatty liver disease; Obesity; Phosphatidylcholine

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN E; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; LEPTIN; PHOSPHATIDYLCHOLINE; SOYBEAN EXTRACT; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; HISTOPATHOLOGY; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; LIVER; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; WEIGHT CHANGE; WEIGHT GAIN; ADIPOCYTE; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECTS; HYPERLIPIDEMIAS; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

MUS;

ADIPOCYTES; ANIMALS; APOLIPOPROTEINS E; DIET, HIGH-FAT; HYPERLIPIDEMIAS; LEPTIN; MALE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PHOSPHATIDYLCHOLINES; WEIGHT GAIN;

EID: 84909646144     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.09.027     Document Type: Article

References (37)

1. Ahmed U, Redgrave TG, Oates PS. Effect of dietary fat to produce non-alcoholic fatty liver in the rat. J Gastroenterol Hepatol 2009;24:1463-71.
2. Amin KA, Nagy MA. Effect of carnitine and herbal mixture extract on obesity induced by high fat diet in rats. Diabetol Metab Syndr 2009;1:17.
3. Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S, Arikan S. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associatedwith inflammation in adults? J Endocrinol Invest 2007;30:210-4.
4. Bannykh SI, Witztum JL, Bergmark C.Mechanical aortic injury in apoE-deficient mice as a model for development of atherosclerosis: demonstration of leukocyte rolling early after injury. Ultrastruct Pathol 2002;26:251-60.
5. Buang Y, Wang YM, Cha JY, Nagao K, Yanagita T. Dietary phosphatidylcholine alleviates fatty liver induced by orotic acid. Nutrition 2005;21:867-73.
6. Couillard C, Mauriege P, Imbeault P, Prud'homme D, Nadeau A, Tremblay A, et al. Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia. Int J Obes Relat Metab Disord 2000;24:782-8.
7. Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010;122:1837-45.
8. Florentin M, Liberopoulos EN, Wierzbicki AS, Mikhailidis DP. Multiple actions of highdensity lipoprotein. Curr Opin Cardiol 2008;23:370-8.
9. ForetzM, Guichard C, Ferre P, Foufelle F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A 1999;96:12737-42.
10. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-70.
11. Gerber L, Otgonsuren M, Mishra A, Escheik C, Birerdinc A, Stepanova M, et al. Nonalcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. Aliment Pharmacol Ther 2012;36:772-81.
12. Hollie NI, Hui DY. Group 1B phospholipase A(2) deficiency protects against diet-induced hyperlipidemia in mice. J Lipid Res 2011;52:2005-11.
13. Horsch AK, Majolk I, Heuck CC, Gopfert E. Effects of polyenylphosphatidylcholine (PPC) on serum lipids in patients with hyperlipoproteinemia. A double-blind study. Vasa 1986;15:251-5.
14. Jiang Y, Noh SK, Koo SI. Egg phosphatidylcholine decreases the lymphatic absorption of cholesterol in rats. J Nutr 2001;131:2358-63.
15. Kang JS, Lee WK, Lee CW, YoonWK, Kim N, Park SK, et al. Improvement of high-fat diet-induced obesity by amixture of red grape extract, soy isoflavone and L-carnitine: implications in cardiovascular and non-alcoholic fatty liver diseases. Food ChemToxicol 2011;49:2453-8.
16. Kang YR, Lee HY, Kim JH, Moon DI, Seo MY, Park SH, et al. Anti-obesity and anti-diabetic effects of Yerba Mate (Ilex paraguariensis) in C57BL/6 J mice fed a high-fat diet. Lab Anim Res 2012;28:23-9.
17. Karaman A, Demirbilek S, Sezgin N, Gurbuz N, Gurses I. Protective effect of polyunsaturated phosphatidylcholine on liver damage induced by biliary obstruction in rats. J Pediatr Surg 2003;38:1341-7.
18. Kawashiri M, Zhang Y, Usher D, Reilly M, Pure E, Rader DJ. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice. J Lipid Res 2001;42:943-50.
19. Krauss RM. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol 2005;25:2265-72.
20. Leibowitz SF, Chang GQ, Dourmashkin JT, Yun R, Julien C, Pamy PP. Leptin secretion after a high-fat meal in normal-weight rats: strong predictor of long-term body fat accrual on a high-fat diet. Am J Physiol Endocrinol Metab 2006;290:E258-67.
21. Loguercio C, Andreone P, Brisc C, BriscMC, Bugianesi E, ChiaramonteM, et al. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med 2012;52:1658-65.
22. Martin-Castillo A, Castells MT, Adanez G, Polo MT, Perez BG, Ayala I. Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens. Biomed Pharmacother 2010;64:275-81.
23. Mastellone I, Polichetti E, Gres S, de la Maisonneuve C, Domingo N, Marin V, et al. Dietary soybean phosphatidylcholines lower lipidemia:mechanisms at the levels of intestine, endothelial cell, and hepato-biliary axis. J Nutr Biochem 2000;11:461-6.
24. Matsubara Y, Kano K, Kondo D, Mugishima H, Matsumoto T. Differences in adipocytokines and fatty acid composition between two adipocyte fractions of small and large cells in high-fat diet-induced obese mice. Ann Nutr Metab 2009;54:258-67.
25. Mirza MS. Obesity, visceral Fat, and NAFLD: querying the role of adipokines in the progression of nonalcoholic fatty liver disease. ISRN Gastroenterol 2011;2011:592404.
26. Monteiro R, de Castro PM, Calhau C, Azevedo I. Adipocyte size and liability to cell death. Obes Surg 2006;16:804-6.
27. Niebergall LJ, Jacobs RL, Chaba T, Vance DE. Phosphatidylcholine protects against steatosis in mice but not non-alcoholic steatohepatitis. Biochim Biophys Acta 2011;1811:1177-85.
28. Nwagha UI, Ikekpeazu EJ, Ejezie FE, Neboh EE, Maduka IC. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. Afr Health Sci 2010;10:248-52.
29. O'Keefe JH, Bell DS. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 2007;100:899-904.
30. Peng ZY, Zhao SP, He BM, Peng DQ, Hu M. Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway. Mol Cell Biochem 2011;351:243-9.
31. Polichetti E, Janisson A, de la Porte PL, Portugal H, Leonardi J, Luna A, et al. Dietary polyenylphosphatidylcholine decreases cholesterolemia in hypercholesterolemic rabbits: role of the hepato-biliary axis. Life Sci 2000;67:2563-76.
32. Sanchez-Castillo CP, Velasquez-Monroy O, Lara-Esqueda A, Berber A, Sepulveda J, Tapia-Conyer R, et al. Diabetes and hypertension increases in a society with abdominal obesity: results of the Mexican National Health Survey 2000. Public Health Nutr 2005;8:53-60.
33. Sarmento A, Soares-da-Silva P, Teixeira AA, Azevedo I. Effects of denervation induced by 6-hydroxydopamine on cell nucleus activity of arterial and cardiac cells of the dog. J Auton Pharmacol 1987;7:119-26.
34. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Moonen-Kornips E, Schaart G, Mustard KJ, et al. Intramyocellular lipid content and molecular adaptations in response to a 1-week high-fat diet. Obes Res 2005;13:2088-94.
35. Shirouchi B, Nagao K, Inoue N, Ohkubo T, Hibino H, Yanagita T. Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats. J Agric Food Chem 2007;55:7170-6.
36. Tonstad S, Despres JP. Treatment of lipid disorders in obesity. Expert Rev Cardiovasc Ther 2011;9:1069-80.
37. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 2008;94:231-41.